JP2022553173A5 - - Google Patents
Info
- Publication number
- JP2022553173A5 JP2022553173A5 JP2022522603A JP2022522603A JP2022553173A5 JP 2022553173 A5 JP2022553173 A5 JP 2022553173A5 JP 2022522603 A JP2022522603 A JP 2022522603A JP 2022522603 A JP2022522603 A JP 2022522603A JP 2022553173 A5 JP2022553173 A5 JP 2022553173A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962915068P | 2019-10-15 | 2019-10-15 | |
| US62/915,068 | 2019-10-15 | ||
| PCT/US2020/055796 WO2021076766A1 (en) | 2019-10-15 | 2020-10-15 | Curcuminoid composition for therapeutic management of metabolic syndrome |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553173A JP2022553173A (ja) | 2022-12-22 |
| JPWO2021076766A5 JPWO2021076766A5 (https=) | 2023-09-22 |
| JP2022553173A5 true JP2022553173A5 (https=) | 2023-09-22 |
Family
ID=75382361
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022522603A Pending JP2022553173A (ja) | 2019-10-15 | 2020-10-15 | 代謝症候群の治療管理のためのクルクミノイド組成物 |
| JP2022522601A Pending JP2022551967A (ja) | 2019-10-15 | 2020-10-15 | クルクミノイド組成物および肺線維症の管理におけるその治療能力 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022522601A Pending JP2022551967A (ja) | 2019-10-15 | 2020-10-15 | クルクミノイド組成物および肺線維症の管理におけるその治療能力 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11707438B2 (https=) |
| EP (2) | EP4045478B1 (https=) |
| JP (2) | JP2022553173A (https=) |
| CN (2) | CN114746102A (https=) |
| CA (2) | CA3153877C (https=) |
| WO (2) | WO2021076766A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230255969A1 (en) * | 2020-07-23 | 2023-08-17 | National University Of Singapore | Targeting immune pathologies induced by highly pathogenic coronaviruses |
| JP2023554640A (ja) * | 2020-12-17 | 2023-12-28 | サミ－サビンサ グループ リミテッド | 慢性炎症状態において終末糖化産物受容体（ｒａｇｅ）を標的とするための組成物 |
| WO2022203674A1 (en) * | 2021-03-25 | 2022-09-29 | Majeed, Muhammed | Compositions and methods for managing nephropathy |
| BR112023022756A2 (pt) * | 2021-04-30 | 2024-01-02 | Sami Sabinsa Group Ltd | Composições para gerenciamento de síndrome de ovário policístico |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0249747A (ja) | 1988-08-12 | 1990-02-20 | Kobe Steel Ltd | 抗酸化剤 |
| US6653327B2 (en) * | 1999-04-09 | 2003-11-25 | Sabinsa Corporation | Cross-regulin composition of tumeric-derived tetrahydrocurcuminoids for skin lightening and protection against UVB rays |
| JP2003002827A (ja) * | 2001-06-20 | 2003-01-08 | Kyowa Hakko Kogyo Co Ltd | 血中中性脂肪の増加の予防又は改善剤 |
| US6790979B2 (en) * | 2002-04-17 | 2004-09-14 | University Of North Carolina At Chapel Hill | Curcumin analogues and uses thereof |
| US8784881B2 (en) * | 2004-03-05 | 2014-07-22 | Board Of Regents, The University Of Texas System | Liposomal curcumin for treatment of diseases |
| US20060263309A1 (en) * | 2005-05-17 | 2006-11-23 | Bissett Donald L | Regulation of mammalian keratinous tissue using personal care compositions comprising tetrahydrocurcumin |
| US20080031980A1 (en) * | 2006-08-02 | 2008-02-07 | Al Rodriguez | Curcumin-containing composition, methods of making, and methods of using |
| US20080058426A1 (en) * | 2006-08-29 | 2008-03-06 | Muhammed Majeed | Composition and method for treating psoriasis |
| CN101255119B (zh) * | 2008-01-07 | 2014-05-21 | 沈阳药科大学 | 四氢姜黄素衍生物及盐类 |
| JP2012521412A (ja) * | 2009-03-23 | 2012-09-13 | ライラ ファーマシューティカルズ ピーブイティ．エルティディ． | 鼻のアレルギー疾患において適用するためのクルクミノイドおよびその代謝物 |
| CN101732292B (zh) * | 2010-01-25 | 2012-05-16 | 四川省中医药科学院 | 四氢姜黄素的用途 |
| CN102526004A (zh) * | 2010-01-25 | 2012-07-04 | 四川省中医药科学院 | 四氢姜黄素的新用途 |
| WO2011124573A1 (en) * | 2010-04-09 | 2011-10-13 | Unilever Plc | Oral care compositions |
| CN102078312A (zh) * | 2010-12-24 | 2011-06-01 | 中国药科大学 | 一种姜黄素类化合物干粉吸入剂及其制备方法和用途 |
| US9170257B2 (en) * | 2012-06-14 | 2015-10-27 | Signpath Pharma Inc. | Method and system for measuring the pharmacokinetics of liposomal curcumin and its metabolite tetrahydrocurcumin |
| US20150283093A1 (en) * | 2014-04-07 | 2015-10-08 | Muhammed Majeed | Nanoencapsulation of curcuminoid metabolites - process, composition and applications thereof |
| US9642886B2 (en) * | 2014-08-25 | 2017-05-09 | Srm University | Plant based formulation for the prevention and management of metabolic syndrome by its adiponectin enhancing property |
| DK3233068T3 (da) * | 2014-12-15 | 2021-09-13 | Aurea Biolabs Private Ltd | Fremgangsmåde til fremstilling af biotilgængelig hvid curcumin - en unik blanding af hydrogenerede curcuminoider |
| KR102876481B1 (ko) * | 2017-03-17 | 2025-10-27 | 케랄라 아유르베다 리미티드 (인디아) | 약초 조성물 |
| CN108771664B (zh) * | 2018-06-05 | 2020-09-08 | 中山大学 | 四氢姜黄素在改善过敏性哮喘的应用 |
| CN109833457A (zh) * | 2019-02-28 | 2019-06-04 | 孟凤仙 | 虎杖及姜黄及其活性物在治疗间质性肺病中的应用 |
| CN109674742A (zh) * | 2019-03-07 | 2019-04-26 | 康赋葆(深圳)生物医药科技有限公司 | 一种姜黄素类亲水凝胶骨架缓释组合物、制备方法及其在抗癌领域的应用 |
-
2020
- 2020-10-15 JP JP2022522603A patent/JP2022553173A/ja active Pending
- 2020-10-15 WO PCT/US2020/055796 patent/WO2021076766A1/en not_active Ceased
- 2020-10-15 EP EP20876349.0A patent/EP4045478B1/en active Active
- 2020-10-15 CN CN202080081641.8A patent/CN114746102A/zh active Pending
- 2020-10-15 CA CA3153877A patent/CA3153877C/en active Active
- 2020-10-15 US US17/071,637 patent/US11707438B2/en active Active
- 2020-10-15 EP EP20877123.8A patent/EP4045071B1/en active Active
- 2020-10-15 JP JP2022522601A patent/JP2022551967A/ja active Pending
- 2020-10-15 US US17/071,682 patent/US11491119B2/en active Active
- 2020-10-15 WO PCT/US2020/055802 patent/WO2021076771A1/en not_active Ceased
- 2020-10-15 CN CN202080079524.8A patent/CN114728876A/zh active Pending
- 2020-10-15 CA CA3153879A patent/CA3153879A1/en active Pending